Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Osom Ultra hCG Combo Test- IVD immunoassay for the qualitative Recalled by Princeton Biomeditech Corp Due to This recall was initiated due to customer complaints...

Date: August 23, 2024
Company: Princeton Biomeditech Corp
Status: Ongoing
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Princeton Biomeditech Corp directly.

Affected Products

Osom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in serum or urine for the early confirmation of pregnancy. Model/Catalog Number: 1004

Quantity: 1,860 kits (50,220 test devices)

Why Was This Recalled?

This recall was initiated due to customer complaints of false negative of hCG test results when running patient urine samples. Use of the above listed product lot may result in false negative results. An end user reported that the OSOM Ultra hCG Combo Test, lot 563L13, produced false negative test results from 2 patient urine samples as confirmed by quantitative hCG and ultrasound. During further root cause testing and investigation, an additional 6 devices were found to produce false negative test results from hCG positive samples.

Where Was This Sold?

This product was distributed to 1 state: MO

Affected (1 state)Not affected

About Princeton Biomeditech Corp

Princeton Biomeditech Corp has 4 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report